Session Type
Meeting
Search Results for Buprenorphine
Abstract Number: 412
Hospital Medicine 2020, Virtual Competition
Background: Opioid use disorder (OUD) is a highly prevalent medical condition that is associated with significant morbidity and mortality. As rates of opioid addiction have increased in the last several years, hospitalists are uniquely positioned at the front lines to initiate evidence-based treatment for patients who are admitted with comorbid OUD and help link patients […]
Abstract Number: 531
SHM Converge 2021
Case Presentation: A 37-year old woman with a past medical history of opioid use disorder (OUD) and hepatitis C was admitted to a tertiary care center for management of septic shock from necrotizing soft tissue infection secondary to injection drug use, requiring multiple operations with subsequent skin grafting. She reported using multiple grams of intravenous […]
Abstract Number: 695
SHM Converge 2021
Case Presentation: AS is 36-year-old woman with methamphetamine and opioid use disorder (OUD) hospitalized with endocarditis who is evaluated by the Addiction Consult Service (ACS), and started on sublingual Buprenorphine/naloxone (Bup/nx) for treatment of OUD. Urine drug screens continue to be inappropriately positive for methamphetamine inpatient. Extended Release Buprenorphine (Bup-XR) is discussed and with her […]
Abstract Number: 793
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: A 34-year-old man with history of injection (IV) heroin misuse, anxiety, and homelessness presents with dyspnea and pleuritic chest pain. He was recently hospitalized with Methicillin-Sensitive Staph Aureus (MSSA) tricuspid valve (TV) endocarditis complicated by acute heart failure and septic pulmonary emboli but left against medical advice. On admission he was afebrile, tachycardic […]
Abstract Number: 812
SHM Converge 2023
Case Presentation: A 34-year-old male with a history of opioid use disorder (OUD) was admitted after being found down secondary to heroin overdose. He was given 4 mg naloxone in the field with improvement in Glasgow Coma Score from 3 to 12. After naloxone administration, he was tachycardic, tachypneic, hypertensive, and agitated. He reported taking […]
Abstract Number: A34
SHM Converge 2022
Case Presentation: A 35-year-old female presented to the emergency department after an episode of syncope. She takes methadone (180 mg/day) for opioid dependency. She had a recent relapse and returned to illicit drug use after a period of sobriety. Vital signs were notable for tachycardia, blood pressure and respiratory rate were normal. On physical exam […]
Oral Presentations
Abstract Number: Oral
SHM Converge 2021
Background: Despite evidence that the use of medications for patients with opioid use disorder (OUD) leads to reduced mortality and improved engagement in outpatient addiction treatment, these life-saving medications are underutilized in the hospital setting. This study reports the outcomes of a hospitalist-led interprofessional and multidisciplinary inpatient program, known as the B-Team (buprenorphine team), to […]